|
US - Bristol-Myers Squibb Co (BM) completed its tender offer to acquire all the outstanding common stock of Kosan Biosciences Inc (KB), a provider of commercial research services, via a tender offer for $#.# in cash per share, or…
|
| Credit & Investment Research |
|
|